# Raytec Biotechnology to build regenerative medicine base in Chengdu Medical City

Raytec Biotechnology signed an agreement to build a regenerative medicine R&D and production base in Chengdu Medical City, Wenjiang District, including 6 production lines for medical restorative devices. The project is part of a 16-project signing event with total investment of approximately 12.4 billion yuan.

- Type: New facility
- Announced: 2020-09-16
- Where: Chengdu Medical City, Wenjiang District, Chengdu, China
- Status: announced
- Products: biological amniotic membrane regenerative repair materials, medical restorative devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Raytec Biotechnology](https://endata.com/companies/50049.md)

## Sources

- [en.raytecbio.com](http://en.raytecbio.com/NewsDetail.aspx?ID=239), 2020-09-21: "The company will build a research and production base for regenerative medicine in Chengdu Medical City, including 6 production lines for medical restorative medical devices in fields such as ophthalmology, dentistry, and orthopedics."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.